ARTICLE | Clinical News
Micromet AG preclinical data
April 11, 2005 7:00 AM UTC
In a mouse model of tumor, IV doses as low as 100 ng of anti-Ep-CAM BiTE daily could effectively prevent subcutaneous tumor outgrowth. Also, 5 daily doses of 10 µg were sufficient to completely eradic...